chr2-47806780-G-GAAGT
Variant summary
Our verdict is Uncertain significance. The variant received 5 ACMG points: 5P and 0B. PVS1_ModeratePM2PP5
The NM_000179.3(MSH6):c.4004_4007dupAAGT(p.Cys1337SerfsTer5) variant causes a frameshift change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. V1336V) has been classified as Likely benign.
Frequency
Consequence
NM_000179.3 frameshift
Scores
Clinical Significance
Conservation
Publications
- intellectual developmental disorder with dysmorphic facies and behavioral abnormalitiesInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 5 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| MSH6 | NM_000179.3 | c.4004_4007dupAAGT | p.Cys1337SerfsTer5 | frameshift_variant | Exon 10 of 10 | ENST00000234420.11 | NP_000170.1 | |
| FBXO11 | NM_001190274.2 | c.*1334_*1337dupACTT | downstream_gene_variant | ENST00000403359.8 | NP_001177203.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| MSH6 | ENST00000234420.11 | c.4004_4007dupAAGT | p.Cys1337SerfsTer5 | frameshift_variant | Exon 10 of 10 | 1 | NM_000179.3 | ENSP00000234420.5 | ||
| FBXO11 | ENST00000403359.8 | c.*1334_*1337dupACTT | downstream_gene_variant | 1 | NM_001190274.2 | ENSP00000384823.4 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
Hereditary cancer-predisposing syndrome Pathogenic:2
This variant is located in the MSH6 protein. Splice site prediction tools suggest that this variant may not impact RNA splicing. This variant has not been identified in the general population by the Genome Aggregation Database (gnomAD). Loss of MSH6 function is a known mechanism of disease (clinicalgenome.org). Based on the available evidence, this variant is classified as Likely Pathogenic. -
The c.4004_4007dupAAGT variant, located in coding exon 10 of the MSH6 gene, results from a duplication of AAGT at nucleotide position 4004, causing a translational frameshift with a predicted alternate stop codon (p.C1337Sfs*5). Frameshifts are typically deleterious in nature; however, this frameshift occurs at the 3' terminus of MSH6, is not expected to trigger nonsense-mediated mRNA decay, and impacts only the last 24 amino acids of the protein. The exact functional impact of these altered amino acids is unknown at this time. In addition, this alteration was identified in an individual with early-onset colon cancer that was MSI-H and displayed isolated loss of MSH6 on immunohistochemistry (Ambry internal data). Based on the majority of available evidence to date, this variant is likely to be pathogenic. -
Hereditary nonpolyposis colorectal neoplasms Uncertain:1
This sequence change inserts 4 nucleotides in exon 10 of the MSH6 mRNA (c.4004_4007dupAAGT), causing a frameshift at codon 1337. This creates a premature translational stop signal in the last exon of the MSH6 mRNA (p.Cys1337Serfs*5). While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 24 amino acids of the MSH6 protein. This variant is not present in population databases (ExAC no frequency). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. This variant has been observed in an individual undergoing multigene panel testing (PMID: 28514183). ClinVar contains an entry for this variant (Variation ID: 230310). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at